OPDP: No More Untitled Letters?
Today marks one year since the Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) issued an Untitled…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
PhRMA Releases Report on Global Prescription Drug Access
The Pharmaceutical Research and Manufacturers of America (PhRMA) recently published a new report that analyzes the share of new…
The Impact of COVID-19 Years on the ACO REACH Model
The impact of the COVID-19 pandemic on accountable care organizations (ACOs) has yet to be determined, but according to the…
PhRMA Focuses on Other Important Health Care System Improvements
The Pharmaceutical Research and Manufacturers of America (PhRMA) recently published a new page on their website covering the Cost…
Pioneer Institute Issues White Paper on Impact of PBMs and Copay…
The Pioneer Institute recently released a white paper that examines the impact of pharmacy benefit managers (PBMs) and copay…
AMA Survey Finds that Prior Authorization Harms Patient Care
A recent physician survey found that the prior authorization process exceeds the benefit of the process to patients, according to…
HHS OIG Releases Telehealth HHS OIG Toolkit
HHS OIG has said that during 2020, the use of telehealth services increased dramatically, with Medicare beneficiaries using 88…
CMS Outlines Medicare Drug Price Negotiation Program for 2026
On March 15, 2023, CMS released initial guidance detailing the requirements and parameters on key elements of the new Medicare…
CMS Releases 2024 MA Capitation Rates and Part C and D Payment Policies
On Friday, March 31, 2023, the Centers for Medicare & Medicaid Services (CMS) released the Calendar Year 2024 Medicare…
Ongoing Litigation Over ACA Provisions that Mandate Health Coverage
On March 30, 2023, the U.S. District Court for the Northern District of Texas vacated actions taken by HHS to implement provisions…